Mesenchymal stromal cells as a potential therapeutic for neurological disorders
- PMID: 30525073
- PMCID: PMC6222283
- DOI: 10.1016/j.reth.2018.08.001
Mesenchymal stromal cells as a potential therapeutic for neurological disorders
Abstract
Several studies have reported that mesenchymal stromal/stem cells (MSCs) restore neurological damage through their secretion of paracrine factors or their differentiation to neuronal cells. Based on these studies, many clinical trials have been conducted using MSCs for neurological disorders, and their safety and efficacy have been reported. In this review, we provide a brief introduction to MSCs, especially umbilical cord derived-MSCs (UC-MSCs), in terms of characteristics, isolation, and cryopreservation, and discuss the recent progress in regenerative therapies using MSCs for various neurological disorders.
Keywords: Cerebral palsy; Mesenchymal stromal cell; Neurological disorders; Neurotrophic factor; Umbilical cord.
References
-
- Chang K.A., Lee J.H., Suh Y.H. Therapeutic potential of human adipose-derived stem cells in neurological disorders. J Pharmacol Sci. 2014;126(4):293–301. - PubMed
-
- Nagamura-Inoue T., Mukai T. Umbilical cord is a rich source of mesenchymal stromal cells for cell therapy. Curr Stem Cell Res Ther. 2016;11(8):634–642. - PubMed
-
- Caplan A.I. Mesenchymal stem cells. J Orthop Res: Off Publ Orthop Res Soc. 1991;9(5):641–650. - PubMed
-
- Friedenstein A.J., Piatetzky S., II, Petrakova K.V. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16(3):381–390. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
